NDC 0641-6001-01 - Ativan

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
0641-6001
Requested NDC
0641-6001-01
Package NDCs from labels
0641-6001-01, 0641-6001-25
Manufacturer
Hikma Pharmaceuticals USA Inc.
Effective date
2026-09-16
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
ATIVAN Injection (lorazepam injection, USP)Hikma Pharmaceuticals USA Inc.2026-09-16HUMAN PRESCRIPTION DRUG LABEL
National Council for Prescription Drug Programs indexing - billing unitNational Council for Prescription Drug Programs2012-07-24Indexing - Billing Unit

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0641-6001-01Ativan1 mL in 1 VIALINJECTION112
0641-6001-25Ativan25 in 1 CARTONINJECTION2512

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0641-6001ATIVAN (LORAZEPAM) INJECTION [HIKMA PHARMACEUTICALS USA INC.]12Current NDC, Legacy NDC, 2 package rows20230408_5fc0e987-61c9-40c4-b0d5-fcea07c8733e.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0641-6001-01ML - Milliliter0641-600179099df4-5e1c-4999-ad3f-6660bcd3569612012-07-24
0641-6001-25ML - Milliliter0641-6001d08bfa29-0451-4bc8-9ea5-5789bf3f944412012-07-24

DailyMed Socrata Ingredients#

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 15 · 300 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LorazepamLORAZEPAMCivica, Inc.5140798d-8571-41fb-84a4-e182aac3f64c2026-11-09Boxed warning, Warnings, Adverse reactionsExact identifier
application number: NDA018140
unii: O26FZP769L
Eyewash Station Additive ConcentrateCHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOLEncon Safety Products, Inc.b5a62567-c9f1-0492-e053-2a95a90ab2472026-11-05WarningsExact identifier
unii: 6DC9Q167V3
Visine Red Eye Total Comfort Multi-SymptomTETRAHYDROZOLINE HYDROCHLORIDE, POLYETHYLENE GLYCOL 400, AND ZINC SULFATE, UNSPECIFIED FORMKenvue Brands LLC5747edef-7a87-41d7-9594-6c78508b9ba22026-11-04WarningsExact identifier
unii: B697894SGQ
LorazepamLORAZEPAMPD-Rx Pharmaceuticals, Inc.1f79a5a1-0c40-45cf-8994-51f5ba3a59382026-11-02Boxed warning, Warnings, Adverse reactionsExact identifier
unii: O26FZP769L
LorazepamLORAZEPAMPD-Rx Pharmaceuticals, Inc.08a30230-fc95-9025-e063-6394a90ae21b2026-10-30Boxed warning, Warnings, Adverse reactionsExact identifier
unii: O26FZP769L
LorazepamLORAZEPAMPAI Holdings, LLC dba PAI Pharma711b60a3-028d-41d4-aa17-8f976e6df23e2026-10-30Boxed warning, Warnings, Adverse reactionsExact identifier
unii: O26FZP769L
LorazepamLORAZEPAMSUN PHARMACEUTICAL INDUSTRIES INC0c1caa9c-9ef1-459c-86c3-adb939130a9f2026-10-29Boxed warning, Warnings, Adverse reactionsExact identifier
unii: O26FZP769L
LorazepamLORAZEPAMPD-Rx Pharmaceuticals, Inc.7afd9a59-3463-4eda-8cf3-ef90be05de3d2026-10-26Boxed warning, Warnings, Adverse reactionsExact identifier
unii: O26FZP769L
LorazepamLORAZEPAMPD-Rx Pharmaceuticals, Inc.7999b9c3-6185-4e4e-a4c3-d5d33d6c31d62026-10-26Boxed warning, Warnings, Adverse reactionsExact identifier
unii: O26FZP769L
BACTERIOSTATICWATERElementco, S.A.P.I. de C.V.5e7465d8-dbe4-2f86-e063-6394a90a8dfb2026-10-23WarningsExact identifier
unii: LKG8494WBH
Visine Red Eye Hydrating ComfortTETRAHYDROZOLINE HYDROCHLORIDE AND POLYETHYLENE GLYCOL 400 SOLUTION/ DROPSSelect Consumer Group5e153070-3668-f3c7-e063-6294a90a373b2026-10-17WarningsExact identifier
unii: B697894SGQ
LorazepamLORAZEPAMPD-Rx Pharmaceuticals, Inc.0681c8db-ff09-4258-a5e0-76a26b0ea0af2026-10-16Boxed warning, Warnings, Adverse reactionsExact identifier
unii: O26FZP769L
Artificial TearsGLYCERINPreferred Pharmaceuticals Inc.dd646c72-8f47-43c6-a734-db0dcc8cd4d12026-10-14WarningsExact identifier
unii: B697894SGQ
Artifical TearsGLYCERIN AND PROPYLENE GLYCOLWal-Mart Stores Inc99cfea82-afb8-4c5f-ac0c-492204a42c082026-10-02WarningsExact identifier
unii: 6DC9Q167V3
LorazepamLORAZEPAMREMEDYREPACK INC.1009c870-fd98-4e3b-81c8-4184036fb8c22026-09-30Boxed warning, Warnings, Adverse reactionsExact identifier
unii: O26FZP769L
LorazepamLORAZEPAMREMEDYREPACK INC.ac1f88c2-2cf2-47de-a612-946cd45030902026-09-29Boxed warning, Warnings, Adverse reactionsExact identifier
unii: O26FZP769L
LorazepamLORAZEPAMUnit Dose Solutions, Inc.5c2cc4eb-cc84-f08c-e063-6394a90a605b2026-09-23Boxed warning, Warnings, Adverse reactionsExact identifier
unii: O26FZP769L
AtivanLORAZEPAMHikma Pharmaceuticals USA Inc.5fc0e987-61c9-40c4-b0d5-fcea07c8733e2026-09-16Boxed warning, Warnings, Adverse reactionsExact identifier
application number: NDA018140
ndc (package): 0641-6003-25
ndc (package): 0641-6001-01
ndc (package): 0641-6003-01
ndc (package): 0641-6000-01
ndc (package): 0641-6000-10
ndc (package): 0641-6001-25
ndc (package): 0641-6002-10
ndc (package): 0641-6002-01
ndc (product): 0641-6001
ndc (product): 0641-6002
ndc (product): 0641-6000
ndc (product): 0641-6003
ndc11 (package): 00641600101
rxcui: 1665327
rxcui: 206820
rxcui: 1665188
rxcui: 1665326
rxcui: 238101
rxcui: 206819
rxcui: 238100
rxcui: 1665190
spl id: fb40dcce-9da3-49b4-9bde-e01a17abeae6
spl set id: 5fc0e987-61c9-40c4-b0d5-fcea07c8733e
unii: O26FZP769L
LorazepamLORAZEPAMClinical Solutions Wholesale, LLCc0810422-b732-4c04-97d8-c1521c401ef42026-09-10Boxed warning, Warnings, Adverse reactionsExact identifier
unii: O26FZP769L
LorazepamLORAZEPAMREMEDYREPACK INC.86630bdd-13ad-4ab5-9e94-fcf2ea2113e12026-09-03Boxed warning, Warnings, Adverse reactionsExact identifier
unii: O26FZP769L

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.